Ribavirin for Chronic Hepatitis Prevention among Patients with Hematologic Malignancies

Ribavirin for Chronic Hepatitis Prevention among Patients with Hematologic Malignancies

Findings among a cohort of 26 patients who had hematologic malignancies and hepatitis E virus (HEV) infection support that HEV can induce chronic hepatitis. However, a 3-month course of ribavirin can induce a rapid viral clearance, reducing the risk for chronic hepatitis and enabling continuation of...

Full description

Bibliographic Details
Main Authors: Suzanne Tavitian, Jean-Marie Peron, Françoise Huguet, Nassim Kamar, Florence Abravanel, Odile Beyne-Rauzy, Lucie Oberic, Stanislas Faguer, Laurent Alric, Murielle Roussel, Clément Gaudin, Loïc Ysebaert, Anne Huynh, Christian Recher
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2015-08-01
Series:Emerging Infectious Diseases
Subjects:
Hepatitis E
hematology
malignancy
chronic hepatitis
cirrhosis
ribavirin
Online Access:https://wwwnc.cdc.gov/eid/article/21/8/15-0199_article

Internet

https://wwwnc.cdc.gov/eid/article/21/8/15-0199_article

Similar Items